XDx's AlloMap Could Reduce Biopsies in Heart Transplant Patients, But Is It Better than Observation?

The results of a recent study suggest that gene expression profiling of peripheral-blood specimens "may offer a reasonable alternative to routine biopsies" for certain heart transplant patients, but future studies will be necessary before the approach could be considered as a substitute.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.